Press release
Liquid Biopsy for Cancer Diagnostics Pipeline Drugs Analysis Report: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Guardant360 CDx assay, Cobas EGFR Mutation Test v2, InVision
The Liquid Biopsy for Cancer Diagnostics Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
DelveInsight's, "Liquid Biopsy for Cancer Diagnostics - Competitive Landscape and Pipeline Analysis, 2023 [https://www.delveinsight.com/report-store/liquid-biopsy-for-cancer-diagnostics-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report provides an understanding of the current competition, pipeline products, and changing market dynamics of the Liquid Biopsy for Cancer Diagnostics market in the 7 major pharmaceutical markets. The report also gives a brief competitive analysis of both the current and emerging products, to help understand the competition in the market.
Some of the key takeaways from the Liquid Biopsy for Cancer Diagnostics Pipeline Report:
* Companies across the globe are diligently working toward developing novel Liquid Biopsy for Cancer Diagnostics treatment therapies with a considerable amount of success over the years. Liquid Biopsy for Cancer Diagnostics Key players such as - Guardant360 CDx assay, Cobas EGFR Mutation Test v2, InVisionFirst, Therascreen PIK3CA test, ArcherMET, ExoDx Prostate Test, Resolution ctDx Lung assay, PlasmaSELECT 64, IvyGene DX Liver Cancer Test, LiquidHallmark test, FoundationOne Liquid, OncoBEAM, and others, are developing therapies for the Liquid Biopsy for Cancer Diagnostics treatment
* Liquid Biopsy for Cancer Diagnostics Emerging therapies such as - CancerIntercept Detect, Exact Science's DNA methylation-based liquid biopsy test, Parsortix, Grail's liquid biopsy cancer test, and others are expected to have a significant impact on the Liquid Biopsy for Cancer Diagnostics market in the coming years.
* On 2nd June 2022, GRAIL revealed a strategic partnership with AstraZeneca aimed at creating and marketing companion diagnostic (CDx) assays tailored for use alongside AstraZeneca's treatments.
Liquid Biopsy for Cancer Diagnostics Overview
Liquid biopsy for cancer diagnostics is a non-invasive method used to detect and analyze tumor-related biomarkers, such as circulating tumor cells (CTCs), cell-free DNA (cfDNA), and extracellular vesicles (EVs), in bodily fluids like blood, urine, or saliva. This technique enables the detection, monitoring, and characterization of tumors without the need for invasive procedures like tissue biopsies.
Get a Free Sample PDF Report to know more about Liquid Biopsy for Cancer Diagnostics Pipeline Assessment- https://www.delveinsight.com/sample-request/liquid-biopsy-for-cancer-diagnostics-pipeline-insight [https://www.delveinsight.com/sample-request/liquid-biopsy-for-cancer-diagnostics-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Liquid Biopsy for Cancer Diagnostics Pipeline Therapeutics Assessment
* Liquid Biopsy for Cancer Diagnostics Assessment by Product Type
* Liquid Biopsy for Cancer Diagnostics By Stage and Product Type
* Liquid Biopsy for Cancer Diagnostics Assessment by Route of Administration
* Liquid Biopsy for Cancer Diagnostics By Stage and Route of Administration
* Liquid Biopsy for Cancer Diagnostics Assessment by Molecule Type
* Liquid Biopsy for Cancer Diagnostics by Stage and Molecule Type
DelveInsight's Liquid Biopsy for Cancer Diagnostics Report covers around 5+ products under different phases of clinical development like
* Late-stage products (Phase III)
* Mid-stage products (Phase II)
* Early-stage product (Phase I)
* Pre-clinical and Discovery stage candidates
* Discontinued & Inactive candidates
* Route of Administration
Key Competitors in Liquid Biopsy for Cancer Diagnostics Pipeline and Market
* Guardant Health
* Roche
* Neo Genomics
* Qiagen
* ArcherDX
* Bio-Techne
* Resolution Bioscience
* Personal Genome Diagnostics
* Laboratory for Advanced Medicine (LAM)
* Lucence Diagnostics
* Foundation Medicine Inc
* Biocept
* Sysmex Ionostics Inc
* Veridex LLC (Janssen Diagnostics)
* Biodesix
* Pathway Genomics
* Exact Sciences
* Angle Plc
* GRAIL Inc.
* NuProbe
* OncoCell MDx Inc
* Merck
* AmoyDx
Liquid Biopsy for Cancer Diagnostics Pipeline Analysis:
The Liquid Biopsy for Cancer Diagnostics pipeline report provides insights into
* The report provides detailed insights about companies that are developing therapies for the Liquid Biopsy for Cancer Diagnostics treatment with aggregate therapies developed by each company for the same.
* It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Liquid Biopsy for Cancer Diagnostics Treatment.
* Liquid Biopsy for Cancer Diagnostics key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
* Liquid Biopsy for Cancer Diagnostics Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
* Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Liquid Biopsy for Cancer Diagnostics market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Further Liquid Biopsy for Cancer Diagnostics product details are provided in the report. Download the Liquid Biopsy for Cancer Diagnostics pipeline report to learn more about the emerging Liquid Biopsy for Cancer Diagnostics therapies [https://www.delveinsight.com/sample-request/liquid-biopsy-for-cancer-diagnostics-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Liquid Biopsy for Cancer Diagnostics Pipeline Market Drivers
* Increasing prevalence of cancer
* Increasing preference for non-invasive procedures
* Availability of funding for liquid biopsy R&D
Liquid Biopsy for Cancer Diagnostics Pipeline Market Barriers
* Lack of harmonization
* The clinical utility of the test results
* Lack of technical knowledge and expertise
Scope of Liquid Biopsy for Cancer Diagnostics Pipeline Drug Insight
* Coverage: Global
* Key Liquid Biopsy for Cancer Diagnostics Companies: Guardant360 CDx assay, Cobas EGFR Mutation Test v2, InVisionFirst, Therascreen PIK3CA test, ArcherMET, ExoDx Prostate Test, Resolution ctDx Lung assay, PlasmaSELECT 64, IvyGene DX Liver Cancer Test, LiquidHallmark test, FoundationOne Liquid, OncoBEAM, and others
* Key Liquid Biopsy for Cancer Diagnostics Therapies: CancerIntercept Detect, Exact Science's DNA methylation-based liquid biopsy test, Parsortix, Grail's liquid biopsy cancer test, and others
* Liquid Biopsy for Cancer Diagnostics Therapeutic Assessment: Liquid Biopsy for Cancer Diagnostics current marketed and Liquid Biopsy for Cancer Diagnostics emerging therapies
* Liquid Biopsy for Cancer Diagnostics Market Dynamics: Liquid Biopsy for Cancer Diagnostics market drivers and Liquid Biopsy for Cancer Diagnostics market barriers
Request for Sample PDF Report for Liquid Biopsy for Cancer Diagnostics Pipeline Assessment and clinical trials [https://www.delveinsight.com/sample-request/liquid-biopsy-for-cancer-diagnostics-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1
Liquid Biopsy for Cancer Diagnostics Report Introduction
2
Liquid Biopsy for Cancer Diagnostics Executive Summary
3
Liquid Biopsy for Cancer Diagnostics Overview
4
Liquid Biopsy for Cancer Diagnostics- Analytical Perspective In-depth Commercial Assessment
5
Liquid Biopsy for Cancer Diagnostics Pipeline Therapeutics
6
Liquid Biopsy for Cancer Diagnostics Late Stage Products (Phase II/III)
7
Liquid Biopsy for Cancer Diagnostics Mid Stage Products (Phase II)
8
Liquid Biopsy for Cancer Diagnostics Early Stage Products (Phase I)
9
Liquid Biopsy for Cancer Diagnostics Preclinical Stage Products
10
Liquid Biopsy for Cancer Diagnostics Therapeutics Assessment
11
Liquid Biopsy for Cancer Diagnostics Inactive Products
12
Company-University Collaborations (Licensing/Partnering) Analysis
13
Liquid Biopsy for Cancer Diagnostics Key Companies
14
Liquid Biopsy for Cancer Diagnostics Key Products
15
Liquid Biopsy for Cancer Diagnostics Unmet Needs
16
Liquid Biopsy for Cancer Diagnostics Market Drivers and Barriers
17
Liquid Biopsy for Cancer Diagnostics Future Perspectives and Conclusion
18
Liquid Biopsy for Cancer Diagnostics Analyst Views
19
Appendix
20
About DelveInsight
Download Sample PDF Report to know more about Liquid Biopsy for Cancer Diagnostics drugs and therapies [https://www.delveinsight.com/sample-request/liquid-biopsy-for-cancer-diagnostics-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=liquid-biopsy-for-cancer-diagnostics-pipeline-drugs-analysis-report-fda-approvals-clinical-trials-therapies-moa-roa-by-delveinsight-guardant360-cdx-assay-cobas-egfr-mutation-test-v2-invision]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liquid Biopsy for Cancer Diagnostics Pipeline Drugs Analysis Report: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Guardant360 CDx assay, Cobas EGFR Mutation Test v2, InVision here
News-ID: 3453851 • Views: …
More Releases from ABNewswire
Understanding Magnetic Switches: Types, Working Principles, and Applications
A magnetic switch is a versatile electrical device that operates by responding to magnetic fields. From Hall Effect to reed switches, explore their functions, types, and diverse applications.
What is a Magnetic Switch?
A magnetic switch is an electrical device that operates by responding to the presence of a magnetic field. It functions by closing or opening its contacts based on the strength of the magnetic field. Specifically, the switch remains closed…
Innovating embedded downlight technology: Leading the global trend of intelligen …
The strong rise of China's manufacturing industry has profoundly reshaped the technological landscape and development trajectory of embedded downlights. With its unparalleled industrial chain advantages, continuous technological innovation, and significant cost-effectiveness, Chinese enterprises have risen from participants in the global lighting industry to undisputed leaders. This transformation goes far beyond the huge production scale; it lies in the thorough innovation of the core technical content and application boundaries of embedded…
North China Electric Power University Foreign Aid Training Program Visits Yiyuan …
On July 23, 2025, the Electrical Industry Training Program of North China Electric Power University's Foreign Aid Project visited Yiyuan Technology for an exchange visit. The purpose was to gain in-depth insights into the company's innovations in renewable energy technology promotion and application [https://www.yiyen.com/about/], and to build bridges connecting university-enterprise cooperation with foreign aid initiatives.
Image: https://ecdn6.globalso.com/upload/p/1108/image_other/2025-07/scene-1.jpg
Image: https://ecdn6.globalso.com/upload/p/1108/image_other/2025-07/scene-3.jpg
Upon arrival, the delegation received a warm welcome from company leadership and the reception…
Pure Sine Wave Low Frequency Inverter Charger
Pure sine wave low frequency inverter [https://www.yiypower.com/ap-mini-600w-1500w-120v-low-frequency-pure-sine-wave-inverter-charger-product/] is widely used and suitable for a variety of scenarios. In terms of home backup power, it can provide reliable power during power outages, ensuring that essential appliances such as refrigerators, air conditioners and medical equipment continue to operate . For solar power generation systems, Inverter charger [https://www.yiypower.com/ap-mini-600w-1500w-120v-low-frequency-pure-sine-wave-inverter-charger-product/] can converter DC Power from Battery, which charged by solar panels, into clean alternating current…
More Releases for Liquid
Vitamins: The Liquid Goldmine in the Booming Liquid Dietary Supplements Market
The liquid dietary supplements market is experiencing a surge in popularity, driven by consumers seeking convenient and effective ways to boost their health and wellness. Among the diverse offerings, the vitamins segment stands out as a high-opportunity area, catering to a wide range of health needs and preferences.
Market Dynamics and Growth Drivers
Liquid vitamins offer a compelling alternative to traditional pills and capsules, providing faster absorption, easier consumption, and customizable dosages.…
Thermoelectric Assemblies Market, By Type (Air to Air, Direct to Air, Liquid to …
The thermoelectric assemblies market is expected to witness market growth at a rate of 8.25% in the forecast period of 2021 to 2028. Data Bridge Market Research report on thermoelectric assemblies market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The rise in the application of thermoelectric assemblies in the food and beverage industry…
Southeast Asia Liquid Gases Market : Growing with a CAGR of 7.1%, By Type (Liqui …
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged products…
Southeast Asia Liquid Gases Market growing with a CAGR of 7.1%, By Type (Liquid …
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged products…
Southeast Asia liquid gases market growing with a CAGR of 7.1%, Size, Share, Tre …
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged products…
Dual Chamber Prefilled Syringes Market 2021 by Product (Liquid/Powder, Liquid/Li …
The Dual Chamber Prefilled Syringes Market report examines the market size by vital countries/regions, product type, application, historical data, and estimate to forecast. It helps to understand the structure of the Dual Chamber Prefilled Syringes Market by recognizing its different sub-segments. Furthermore, the report focuses on key market players to determine, describe and analyze the value, market share, market competition landscape, SWOT analysis, and development plans in the next few…
